Cargando…
An Insight into Potential Pharmacotherapeutic Agents for Painful Diabetic Neuropathy
Diabetes is the 4(th) most common disease affecting the world's population. It is accompanied by many complications that deteriorate the quality of life. Painful diabetic neuropathy (PDN) is one of the debilitating consequences of diabetes that effects one-third of diabetic patients. Unfortunat...
Autores principales: | Qureshi, Zunaira, Ali, Murtaza Najabat, Khalid, Minahil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813291/ https://www.ncbi.nlm.nih.gov/pubmed/35127954 http://dx.doi.org/10.1155/2022/9989272 |
Ejemplares similares
-
Present and future pharmacotherapeutic agents in heart failure: an evolving paradigm
por: Loudon, Brodie L, et al.
Publicado: (2016) -
Pharmacotherapeutic targets in Alzheimer's disease
por: Biran, Yif'at, et al.
Publicado: (2009) -
Pharmacotherapeutic considerations for use of cannabinoids to relieve pain in patients with malignant diseases
por: Darkovska-Serafimovska, Marija, et al.
Publicado: (2018) -
Are AMPA Receptor Positive Allosteric Modulators Potential Pharmacotherapeutics for Addiction?
por: Watterson, Lucas R., et al.
Publicado: (2013) -
Evolutionary perspective of drug eluting stents: from thick polymer to polymer free approach
por: Hassan, Sadia, et al.
Publicado: (2022)